Report offers ways to address cybersecurity challenges posed by legacy medical devices
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
The Food and Drug Administration released draft guidance Sept. 24 that includes recommendations on non-clinical testing, clinical data and labeling for…
Headline
The FBI and the Cybersecurity and Infrastructure Security Agency have released a fact sheet for critical infrastructure organizations on ways to reduce risk…
Headline
The AHA will host a webinar Sept. 30 at 1 p.m. ET on ways healthcare organizations can build an effective, closed-loop cybersecurity program designed…
Headline
New guidance from the Cybersecurity and Infrastructure Security Agency encourages healthcare organizations to consider internal network and internet facing…
Headline
The National Institute of Standards and Technology and the Cybersecurity and Infrastructure and Security Agency have released guidelines to protect…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…